查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球血管成形术球囊市场 - 2023-2030年
市场调查报告书
商品编码
1297818

全球血管成形术球囊市场 - 2023-2030年

Global Angioplasty Balloons Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球血管成形术球囊市场在2022年达到22亿美元，预计到2030年将见证有利可图的增长，达到29亿美元。在预测期内（2023-2030年），全球血管成形术球囊市场预计将呈现3.5%的复合增长率。

血管成形术球囊主要用于治疗冠状动脉疾病（CAD），这种疾病是由于斑块在动脉内堆积，导致其变窄或堵塞而发生的。用球囊进行血管成形术是一种微创手术，可以通过皮肤上的一个小切口进行，通常在腹股沟或手腕部位。

生活方式相关疾病的发生率增加和对微创手术的需求增加等因素，预计将推动市场发展。此外，先进技术的迅速采用，特别是在发达国家，在血管成形术领域，包括这种药物洗脱和切割球囊，估计将推动整个预测期的市场增长。

市场动态

对公司战略和研发的进一步关注将推动市场增长

对公司战略和研发的日益关注将推动市场的增长。例如，2021年6月17日，部门资产管理公司向Cagent Vascular Inc.投资900万美元，该公司是采用独特锯齿技术的下一代血管成形术球囊的生产商。除投资外，Marc-Andre Marcotte已加入董事会。这些资金将用于加快Serranator膝下型（BTK）产品的商业化和规模化。

此外，2022年4月22日，Accumed Radial Systems宣布与POBA Medical, Inc.达成战略协议，为我们的创新、专有和改变游戏规则的Accumed Radial Intra Vascular Extension（ARIVE）技术创造原型。POBA将与Accumed Radial团队合作，为多种应用建立ARIVE原型，同时提供设计、制造和扩大规模的专业知识。POBA将同时对Accumed Radial进行投资。上述因素预计将在预测期内推动市场扩张。

冠状动脉和周边动脉疾病发病率的增加可能会促进市场增长

周边和冠状动脉疾病是动脉粥样硬化的常见症状，可导致中风、心肌梗塞和/或心血管疾病的死亡。这些疾病的发病率不断上升，预计将在接下来的几年里推动市场扩张。根据CDC的数据，冠心病是最常见的心脏病类型，到2021年约有375,000人死亡。20岁及以上的人中，大约每20人中就有1人受CAD影响。

2021年，每10个死于CAD的人中有近2个将发生在65岁以下的人身上。因此，冠心病正在上升，促进了市场增长。

血管成形术的高成本和术后并发症可能会阻碍市场增长

与血管成形术相关的高成本和术后困难预计将扼杀市场扩张。根据美国国家医学图书馆的数据，每次手术的平均总费用（包括门诊费用）为21,893美元，而且血管成形术后6至10小时内会出现再狭窄、心脏病发作、心室颤动、心肌梗塞、支架错位、动脉瘤、肾衰竭和癫痫发作等并发症。这些因素可能会阻碍市场增长。

COVID-19影响分析

根据2020年9月发布的一项研究，目前COVID-19大流行期间的心脏手术对心脏病人和护理这些病人的医护人员都构成了综合危险，因为他们现在因COVID-19而出现并发症的风险更高。此外，美国外科医生学会和美国麻醉师学会建议在COVID-19检测结果出来后，将选择性心脏手术推迟至少14天。

由于围绕COVID-19的各种考虑，预计选择性血管成形手术将被暂停，从而影响血管成形球囊的使用。在此期间，市场可能会经历很少，如果有的话，增长。

俄罗斯-乌克兰战争影响分析

俄罗斯-乌克兰估计对全球血管成形术球囊市场的影响很小，因为该地区流行率低，没有主要市场参与者。然而，在预测期内，原材料、测试产品和设备的进出口的影响预计对全球血管成形术球囊市场的影响很小。

人工智能影响分析

人工智能预计将对全球血管成形术球囊市场产生积极的影响。由于人工智能算法可以分析医疗图像，如血管造影或计算机断层扫描（CTA）扫描，以协助识别和定位血管内的病变或堵塞。

这种分析通过深入了解堵塞物的大小、位置和严重程度，帮助介入心脏病专家规划血管成形术。值得注意的是，虽然人工智能在协助血管成形球囊手术方面显示出巨大的潜力，但它应始终作为一种工具来支持医疗保健专业人士，而不是取代他们的专业知识和判断。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按产品类型分類的摘要
  • 按应用分类的摘要
  • 按终端用户分类
  • 按地区分类

第四章：动态变化

  • 影响因素
    • 驱动因素
      • 冠状动脉和周边动脉疾病的发病率不断上升
      • 对公司战略和研发的重视程度增加
    • 限制因素
      • 血管成形术的高成本和术后并发症
    • 机会
      • 对微创手术的偏爱
    • 影响分析

第五章：行业分析

  • 波特五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析

第六章：COVID-19分析

  • 对COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第7章 ：俄罗斯-乌克兰战争分析

第八章：人工智能影响分析

第九章：按产品类型

  • 药物洗脱球囊
  • 普通球囊
  • 切割/刻痕球囊

第十章：按应用分类

  • 冠状动脉血管成形术
  • 周边血管成形术

第十一章：按终端用户分类

  • 医院
  • 非住院手术中心
  • 其他

第十二章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第13章 ：竞争格局

  • 竞争格局
  • 市场份额分析
  • 合併和收购分析

第十四章：公司简介

  • Boston Scientific Corporation
    • 公司概述
    • 产品组合和描述
    • 财务概况
    • 主要发展情况
  • BIOTRONIK
  • Medtronic Plc
  • Cordis (Cardinal Health)
  • Terumo Corporation
  • Abbott Laboratories
  • AngioDynamics
  • BD
  • INFINITY Angioplasty Balloon
  • Koninklijke Philips N.V.

第十五章 ：附录

简介目录
Product Code: MD4315

Market Overview

The Global Angioplasty Balloons Market reached US$ 2.2 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 2.9 billion by 2030. The global angioplasty balloons market market is expected to exhibit a CAGR of 3.5% during the forecast period (2023-2030).

Angioplasty balloons are primarily used in the treatment of coronary artery disease (CAD), which occurs due to the buildup of plaque within the arteries, leading to their narrowing or blockage. Angioplasty with balloons is a minimally invasive procedure that can be performed through a small incision in the skin, often in the groin or wrist area.

Factors such as the increased occurrence of lifestyle-related disorders and the increasing demand for minimally invasive procedures are anticipated to propel the market. Moreover, the Rapid adoption of advanced technologies, particularly in the developed world, in the angioplasty segment, including such drug-eluting and cutting balloons, is estimated to drive market growth throughout the forecast period.

Market Dynamics

The Increased Focus on Companies Strategies and R&D will Drive the Market Growth

The increased focus on companies strategies and R&D will drive the market growth. For instance, on June 17, 2021, Sectoral Asset Management has made a $9 million investment in Cagent Vascular Inc., a producer of next generation angioplasty balloons using unique serration technology. Marc-Andre Marcotte has joined the board of directors in addition to the investment. The funds will be used to expedite the commercialization and scaling of the Serranator below-the-knee (BTK) product.

Additionally, on April 22, 2022, Accumed Radial Systems announce a strategic agreement with POBA Medical, Inc. to create prototypes of our innovative, proprietary, and game-changing Accumed Radial Intra Vascular Extension (ARIVE) technology. POBA will collaborate with Accumed Radial teams to build ARIVE prototypes for multiple applications, while providing design, manufacturing, and scale-up expertise. POBA will invest in Accumed Radial at the same time. The aforementioned factors are projected to fuel market expansion over the forecast period.

Increasing Incidence of Coronary and Periphery Artery Diseases is Likely to Boost the Market Growth

Peripheral and coronary artery disease are frequent symptoms of atherosclerosis and can lead to stroke, myocardial infarction, and/or death from cardiovascular disease. The rising prevalence of these disorders is expected to drive market expansion in the following years. According to the CDC, coronary heart disease is the most frequent type of heart disease, killing around 375,000 individuals by 2021. CAD affects about one in every twenty persons aged 20 and over.

In 2021, almost 2 out of every 10 deaths from CAD will occur in persons under the age of 65. As a result, coronary heart disease is on the rise, contributing to market growth.

High Costs And the Post-Operational Complications Associated with Angioplasty are Likely to Hamper the Market Growth

High costs and post-operative difficulties associated with angioplasty are expected to stifle market expansion. According to the National Library of Medicine, the average total charge per procedure, including outpatient charges, was $21,893, and complications such as restenosis, heart attack, ventricular fibrillation, myocardial infarction, misplacement of a stent, aneurysms, kidney failure, and seizures occurred within 6 to 10 hours of angioplasty. These elements are likely to hinder market growth.

COVID-19 Impact Analysis

According to a study released in September 2020, cardiac surgery during the present COVID-19 pandemic poses a combined danger for both cardiac patients, who are now at a higher risk of complications due to COVID-19, and the healthcare staff who care for these patients. Furthermore, the American College of Surgeons and the American Society of Anesthesiologists recommended postponing elective heart surgery for at least 14 days following a COVID-19 test result.

As a result of the various considerations surrounding COVID-19, elective angioplasty surgeries are projected to be suspended, affecting the use of angioplasty balloons. During this period, the market may experience little, if any are present, growth.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global angioplasty balloons market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global angioplasty balloons market in the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact the global angioplasty balloons market positively . Due to AI algorithms can analyze medical images, such as angiograms or computed tomography angiography (CTA) scans, to assist in the identification and localization of lesions or blockages within the blood vessels.

This analysis helps the interventional cardiologist in planning the angioplasty procedure by providing insights into the size, location, and severity of the blockage. It's important to note that while AI shows great potential in assisting with angioplasty balloon procedures, it should always be used as a tool to support healthcare professionals rather than a replacement for their expertise and judgment.

Segment Analysis

The global angioplasty balloons market is segmented based on product type, application, end user, and region.

The Hospital Segment is Estimated to Hold around 34.5% of the Angioplasty Balloons Market Share During the Forecast Period

The hospital segment holds about 34.5% of the total angioplasty balloons market in the forecast period. The significant increase in the older population suffering from lifestyle disorders including atherosclerosis and heart failure is predicted to increase the patient pool and boost hospital income production. Furthermore, as compared to traditional operations, the numerous benefits of minimally invasive surgeries, such as reduced surgical discomfort, injury, scarring, hospital stay, higher accuracy, and faster recovery time, motivate more patients to choose minimally invasive balloon angioplasty surgeries.

For instance, according to the American College of Cardiology, roughly 2.1 million angioplasties are performed in the United States per year in 2020. Furthermore, hospitals are likely to attract a big patient base due to their greater accessibility and affordability when compared to speciality clinics. All of these factors are projected to have an impact on segment growth.

Geographical Analysis

North America is Estimated to Hold the Largest Share of the Global Angioplasty Balloons Market During the Forecast Period

The North America region holds the largest share of the global angioplasty balloons market accounting for approximately 40.1% in the forecast period. North America accounted for the maximum revenue share in the angioplasty balloons market. The presence of key industry players, the rising healthcare expenditure, and the increasing product approvals by regulatory bodies in the United States are expected to drive the market's growth.

For instance, on January 2, 2023, the Stellarex 0.035 OTW Drug-coated Angioplasty Balloon from Philips Image Guided Therapy Corp. has been approved by the US Food and Drug Administration (FDA). Stellarex 0.035 OTW Drug-coated angioplasty balloon (Stellarex 035 DCB) reopens blocked or restricted arteries in the thigh and knee caused by peripheral arterial disease (PAD). These advancements are projected to strengthen the region's market's robust product portfolio.

Competitive Landscape

The major global players in the market include: Boston Scientific Corporation, BIOTRONIK, Medtronic Plc, Cordis (Cardinal Health), Terumo Corporation, Abbott Laboratories, AngioDynamics, BD, INFINITY Angioplasty Balloon, and Koninklijke Philips N.V, among others.

Why Purchase the Report?

  • To visualize the global angioplasty balloons market segmentation based on product type, application, end user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of angioplasty balloons market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global angioplasty balloons market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing incidence of coronary and periphery artery diseases
      • 4.1.1.2. The increased focus on companies strategies and R&D
    • 4.1.2. Restraints
      • 4.1.2.1. High costs and the post-operational complications associated with angioplasty
    • 4.1.3. Opportunity
      • 4.1.3.1. Preference for minimally invasive procedures
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario before COVID-19
    • 6.1.2. Scenario during COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Impact Analysis

9. By Product Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 9.1.2. Market Attractiveness Index, By Product type
  • 9.2. Drug Eluting Balloons
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Normal Balloons
  • 9.4. Cutting/Scoring Balloons

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Coronary Angioplasty
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Peripheral Angioplasty

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.6.1. The U.S.
      • 12.2.6.2. Canada
      • 12.2.6.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.6.1. Germany
      • 12.3.6.2. The U.K.
      • 12.3.6.3. France
      • 12.3.6.4. Italy
      • 12.3.6.5. Spain
      • 12.3.6.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.6.1. Brazil
      • 12.4.6.2. Argentina
      • 12.4.6.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.6.1. China
      • 12.5.6.2. India
      • 12.5.6.3. Japan
      • 12.5.6.4. Australia
      • 12.5.6.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Boston Scientific Corporation
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. BIOTRONIK
  • 14.3. Medtronic Plc
  • 14.4. Cordis (Cardinal Health)
  • 14.5. Terumo Corporation
  • 14.6. Abbott Laboratories
  • 14.7. AngioDynamics
  • 14.8. BD
  • 14.9. INFINITY Angioplasty Balloon
  • 14.10. Koninklijke Philips N.V.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us